Lorena Landuzzi

Istituto Ortopedico Rizzoli — Italy

Immunology and Microbiology · Life Sciences

40h-index5.2kcitations232works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(59), Sarcoma Diagnosis and Treatment(51), Cancer-related gene regulation(38), Immune cells in cancer(37), Monoclonal and Polyclonal Antibodies Research(33)

Publications232 total

The ITCC-P4 PDX platform of pediatric cancers for preclinical testing
2026Open Access
Genomic Profiling of Highly Aggressive Musculoskeletal Sarcomas Identifies Potential Therapeutic Targets: A Single-Center Experience
Cancers·2025Open Access
Figure 3 from Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma
2025Open Access
Genomic profiling of a collection of patient-derived xenografts and cell lines identified ixabepilone as an active drug against chemo-resistant osteosarcoma
Journal of Experimental & Clinical Cancer Research·2025Open Access
Abstract 7034: The impact of EphA2 in the malignancy of CIC-DUX sarcomas
Cancer Research·2025
Chondrosarcoma: New Molecular Insights, Challenges in Near-Patient Preclinical Modeling, and Therapeutic Approaches
International Journal of Molecular Sciences·2025· 9 citedOpen Access
Additional file 11 of Genomic profiling of a collection of patient-derived xenografts and cell lines identified ixabepilone as an active drug against chemo-resistant osteosarcoma
Figshare·2025Open Access
Additional file 9 of Genomic profiling of a collection of patient-derived xenografts and cell lines identified ixabepilone as an active drug against chemo-resistant osteosarcoma
Figshare·2025Open Access
Lipid rafts, caveolae, and epidermal growth factor receptor family: friends or foes?
Cell Communication and Signaling·2024· 31 citedOpen Access
CD99 contributes to the EWS::FLI1 transcriptome by specifically affecting FOXM1‐targets involved in the G2/M cell cycle phase, thus influencing the Ewing sarcoma genetic landscape
Journal of Cell Communication and Signaling·2024· 1 citedOpen Access
Supplementary Figure 2 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
2024Open Access
Supplementary Figure 7 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
2024Open Access
Supplementary Figure 5 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
2024Open Access
Supplementary video 3 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
2024Open Access
Supplementary video 2 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
2024Open Access
Supplementary video 1 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
2024Open Access
Supplementary Figure 4 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
2024Open Access
Supplementary Figure 11 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
2024Open Access
Supplementary Figure 5 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
2024Open Access
Supplementary Figure 9 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
2024Open Access
page 1 of 12Next →

Frequent Co-authors

Pier‐Luigi Lollini(47), Patrizia Nanni(41), Giordano Nicoletti(39), Carla De Giovanni(32), Katia Scotlandi(20), Maria Cristina Manara(13), Stefania Croci(13), Annalisa Astolfi(12), Piero Picci(12), Piero Musiani(11), Arianna Palladini(11), Manuela Iezzi(9), Emma Di Carlo(8), Guido Forni(8), Federica Cavallo(8), Massimo Serra(8), Marianna L. Ianzano(7), Mario P. Colombo(6), Ilaria Rossi(5), Cinzia Ricci(5)